Global Transplant Diagnostics Market To Grow At A CAGR of 7.7% During 2018-2022

Global Transplant Diagnostics Market To Grow At A CAGR of 7.7% During 2018-2022

Transplant Diagnostics Global Market Report 2019
Illumina, Inc. Is One Of The Largest Companies In The Transplant Diagnostics Market, According To TBRC’s Report
(Companies: Thermo Fisher Scientific, Inc., Illumina, Inc., F. Hoffmann La-Roche AG, Abbott Laboratories, Inc. and Qiagen N.V)

The global transplant diagnostics market was valued at about $0.69 billion in 2018. North America was the largest region in the transplant diagnostics market in 2018. This region is expected to remain the largest during the next five years. Transplant diagnostics are the tests conducted before relocation/ transplantation of the donor organ to recipient patient. The related services includes only installation and maintenance services offered by equipment manufacturers. Transplant diagnostics tests include Human leukocyte antigen (HLA) diagnostic testing, PCR-based assay, serological assay and mixed lymphocyte culture (MLC) assay among others. 

The global transplant diagnostics market (Read More @ https://www.thebusinessresearchcompany.com/report/transplant-diagnostics-global-market-report)  is expected to grow to $0.93 billion at a rate of about 7.7% through 2022. Rising incidents of acute diseases are leading to an increase in organ failure rates, thus increasing the demand for transplant procedures driving the transplant diagnostics market. Organ transplant is a complex process and the success of the procedure depends on the acceptance of the donor’s organ by the recipient’s body system. In order to check whether the organ transplant can be successful, transplant diagnostic tests are performed.

Huge gap between organ donation and demand for organ transplantation is restraining the growth of the transplant diagnostics market. Companies in the in the transplant diagnostics market are using the Next Generation Sequencing (NGS) for conducting tests to match organ donors and recipients. NGS technology allows the sequencing of an entire human genome, i.e. millions of DNA molecules within a single day. In Next-generation sequencing (NSG), genes are matched between the donor and recipient and depending on the extent of match, decision to perform organ transplantation is made. Nearly all transplant diagnostic tests and devices currently use this technology to decide on organ transplantation.

Major players in the market are Thermo Fisher Scientific, Inc., Illumina, Inc., F. Hoffmann La-Roche AG., Abbott Laboratories, Inc. and Qiagen N.V. Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function.

Request a Sample of This Research @ https://www.thebusinessresearchcompany.com/sample.aspx?id=2481&type=smp . 

Few Points From Table of Contents: 

3. Transplant Diagnostics Market Size And Growth

3.1. Global Transplant Diagnostics Historic Market, 2014 – 2018, $ Billion

3.1.1. Drivers Of The Market

3.1.2. Restraints On The Market

3.2. Global Transplant Diagnostics Forecast Market, 2018 – 2022F, 2025F, 2030F, $ Billion

3.2.1. Drivers Of The Market

3.2.2. Restraints On the Market

4. Transplant Diagnostics Market Segmentation

4.1. Global Transplant Diagnostics Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Reagent & Consumables

Instrument

Software & Services

4.2. Global Transplant Diagnostics Market, Segmentation By Transplant Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Solid Organ

Stem Cell

Soft Tissue

4.3. Global Transplant Diagnostics Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Hospitals and Transplant Centers

Research Laboratories & Transplant Centers

Commercial Service Providers

4.4. Global Transplant Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Non Molecular Assay

Molecular Assay

4.5. Global Transplant Diagnostics Market, Segmentation By Organ, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Place a Direct Purchanse Order @ https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2481

 

About The Business Research Company

The Business Research Company is a Business Intelligence Company which excels in company, market and consumer research. It has offices in the UK, the US and India and a network of trained researchers in 15 countries globally.

Contact Information

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 8897263534

Americas: +1 315 623 0293

Email: info@tbrc.info

Follow us on LinkedIn: https://in.linkedin.com/company/the-business-research-company

Media Contact
Company Name: The Business Research Company
Contact Person: Nitin
Email: Send Email
Phone: 08897263534
Address:1st Floor, Anshu Colors Building, Road Number 1 Park View Enclave, Jubilee Hills
City: Hyderabad 500033
State: Telengana
Country: India
Website: https://www.thebusinessresearchcompany.com/report/transplant-diagnostics-global-market-report